Sarah C. Nabinger

1.4k total citations
23 papers, 637 citations indexed

About

Sarah C. Nabinger is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Sarah C. Nabinger has authored 23 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Immunology. Recurrent topics in Sarah C. Nabinger's work include Protein Tyrosine Phosphatases (6 papers), Acute Myeloid Leukemia Research (4 papers) and Advanced Breast Cancer Therapies (4 papers). Sarah C. Nabinger is often cited by papers focused on Protein Tyrosine Phosphatases (6 papers), Acute Myeloid Leukemia Research (4 papers) and Advanced Breast Cancer Therapies (4 papers). Sarah C. Nabinger collaborates with scholars based in United States, Japan and Germany. Sarah C. Nabinger's co-authors include Rebecca J. Chan, Zhenyun Yang, Yantao He, Yuanshu Dong, Zhong‐Yin Zhang, Li Wu, Andrea Gunawan, Sijiu Liu, Romil Saxena and Xian Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Sarah C. Nabinger

23 papers receiving 633 citations

Peers

Countries citing papers authored by Sarah C. Nabinger

Since Specialization

Citations

This map shows the geographic impact of Sarah C. Nabinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah C. Nabinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah C. Nabinger more than expected).

Fields of papers citing papers by Sarah C. Nabinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah C. Nabinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah C. Nabinger. The network helps show where Sarah C. Nabinger may publish in the future.

Co-authorship network of co-authors of Sarah C. Nabinger

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah C. Nabinger. A scholar is included among the top collaborators of Sarah C. Nabinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah C. Nabinger. Sarah C. Nabinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase 1b/2 study of abemaciclib combined with chemoimmunotherapy in pediatric and young adult patients with relapsed/refractory neuroblastoma (JPCS Part C). 2023 ·Journal of Clinical Oncology ·Emily Greengard, (unknown), (unknown), Noah Federman, (unknown), (unknown), Yanhong Zhou, Holly Knoderer, Sarah C. Nabinger, Lindsey M. Hoffman	2
2	Adjuvant Abemaciclib Combined with Endocrine Therapy: Efficacy Results in monarchE Cohort 1 2022 ·The Oncologist ·Masakazu Toi, Frances Boyle, Young‐Hyuck Im, Mattea Reinisch, (unknown), Zefei Jiang, Ran Wei, Francisco Sapunar, Brenda R. Grimes, Sarah C. Nabinger, Stephen Johnston	12
3	59MO Adjuvant abemaciclib combined with endocrine therapy (ET): Efficacy results in monarchE cohort 1 2022 ·Annals of Oncology ·Masakazu Toi, F. Boyle, Young‐Hyuck Im, Mattea Reinisch, (unknown), (unknown), Ran Wei, Francisco Sapunar, Brenda R. Grimes, Sarah C. Nabinger, Stephen Johnston	3
4	VP8-2021: Adjuvant abemaciclib combined with endocrine therapy (ET): Updated results from monarchE 2021 ·Annals of Oncology ·Joyce O’Shaughnessy, Priya Rastogi, Nadia Harbeck, Masakazu Toi, Roberto Hegg, Joohyuk Sohn, Valentina Guarneri, Javier Cortés, E.P. Hamilton, Ran Wei, Ashwin Shahir, Belén San Antonio, Sarah C. Nabinger, Sara M. Tolaney, Miguel Martín, Stephen Johnston	5
5	The Role and Therapeutic Potential of miRNAs in Colorectal Liver Metastasis 2019 ·PMC ·(unknown), Shatovisha Dey, Sarah C. Nabinger, Guanglong Jiang, Alison M. Bates, Hiromi Tanaka, Yunlong Liu, Janaiah Kota	1
6	The Role and Therapeutic Potential of miRNAs in Colorectal Liver Metastasis 2019 ·Scientific Reports ·(unknown), Shatovisha Dey, Sarah C. Nabinger, Guanglong Jiang, Alison M. Bates, Hiromi Tanaka, Yunlong Liu, Janaiah Kota	17
7	Lower expression of tumor microRNA‐26a is associated with higher recurrence in patients with hepatocellular carcinoma undergoing surgical treatment 2018 ·Journal of Surgical Oncology ·(unknown), Sarah C. Nabinger, Sang Bin Lee, (unknown), Sandra K. Althouse, Romil Saxena, (unknown), Naga Chalasani, Samer Gawrieh, Janaiah Kota	9
8	Pathophysiological role of microRNA-29 in pancreatic cancer stroma 2015 ·IUScholarWorks (Indiana University) ·Jason J. Kwon, Sarah C. Nabinger, (unknown), (unknown), Ravi Kumar Alluri, Zahi Abdul Sater, Zhangsheng Yu, Jesse Gore, Grzegorz Nalepa, Romil Saxena, Murray Korc, Janaiah Kota	2
9	Pathophysiological role of microRNA-29 in pancreatic cancer stroma 2015 ·Scientific Reports ·Jason J. Kwon, Sarah C. Nabinger, (unknown), (unknown), Ravi Kumar Alluri, Zahi Abdul Sater, Zhangsheng Yu, Jesse Gore, Grzegorz Nalepa, Romil Saxena, Murray Korc, Janaiah Kota	62
10	Protein-tyrosine Phosphatase Shp2 Positively Regulates Macrophage Oxidative Burst 2014 ·Journal of Biological Chemistry ·Xing Jun Li, Charles B. Goodwin, Sarah C. Nabinger, (unknown), Zhenyun Yang, Helmut Hanenberg, Hiroshi Ohnishi, Takashi Matozaki, Gen‐Sheng Feng, Rebecca J. Chan	28
11	The protein tyrosine phosphatase, Shp2, positively contributes to FLT3-ITD-induced hematopoietic progenitor hyperproliferation and malignant disease in vivo 2012 ·Leukemia ·Sarah C. Nabinger, Xiaojun Li, Baskar Ramdas, Yantao He, (unknown), Li‐Fan Zeng, (unknown), (unknown), Seiji Fukuda, Shreevrat Goenka, Zhiping Liu, (unknown), Meiwen Yu, George E. Sandusky, H. Scott Boswell, Ze-Yan Zhang, Reuben Kapur, Rebecca J. Chan	35
12	Shp2 function in hematopoietic stem cell biology and leukemogenesis 2012 ·Current Opinion in Hematology ·Sarah C. Nabinger, Rebecca J. Chan	23
13	Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT 2012 ·Blood ·Raghuveer Singh Mali, Peilin Ma, Li‐Fan Zeng, Holly Martin, Baskar Ramdas, Yantao He, Emily Sims, Sarah C. Nabinger, Joydeep Ghosh, (unknown), Veerendra Munugalavadla, Anindya Chatterjee, Shuo Li, George E. Sandusky, Andrew W. Craig, Kevin D. Bunting, Gen‐Sheng Feng, Rebecca J. Chan, Zhong-Yin Zhang, Reuben Kapur	44
14	The Adaptor Protein AMOT Promotes the Proliferation of Mammary Epithelial Cells via the Prolonged Activation of the Extracellular Signal-Regulated Kinases 2011 ·Cancer Research ·William P. Ranahan, Han Zhang, (unknown), Sarah C. Nabinger, Brigitte Heller, Brittney‐Shea Herbert, Rebecca J. Chan, Clark D. Wells	43
15	Rho Kinase Regulates the Survival and Transformation of Cells Bearing Oncogenic Forms of KIT, FLT3, and BCR-ABL 2011 ·Cancer Cell ·Raghuveer Singh Mali, Baskar Ramdas, Peilin Ma, Jianjian Shi, Veerendra Munugalavadla, Emily Sims, Lei Wei, Sasidhar Vemula, Sarah C. Nabinger, Charles B. Goodwin, Rebecca J. Chan, Fabı́ola Traina, Valeria Visconte, Ramón V. Tiu, Timothy A. Lewis, Andrew M. Stern, Qiang Wen, John D. Crispino, H. Scott Boswell, Reuben Kapur	79
16	Thrice weekly azacitidine does not improve hematological responses in lower-risk myelodysplastic syndromes: A study of the Hoosier Oncology Group 2011 ·Leukemia Research ·Hamid Sayar, Rebecca J. Chan, Christie M. Orschell, Edward M. Chan, Zhangsheng Yu, (unknown), (unknown), Zhenyun Yang, (unknown), Sarah C. Nabinger, (unknown), (unknown), (unknown), Carol H. Sampson, Jingwei Wu, Larry D. Cripe	5
17	Salicylic Acid Based Small Molecule Inhibitor for the Oncogenic Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2) 2010 ·Journal of Medicinal Chemistry ·Xian Zhang, Yantao He, Sijiu Liu, Zhihong Yu, Zhong‐Xing Jiang, Zhenyun Yang, Yuanshu Dong, Sarah C. Nabinger, Li Wu, Andrea Gunawan, Lina Wang, Rebecca J. Chan, Zhong‐Yin Zhang	158
18	Increased c-Jun Expression and Reduced GATA2 Expression Promote Aberrant Monocytic Differentiation Induced by Activating PTPN11 Mutants 2009 ·Molecular and Cellular Biology ·Zhenyun Yang, Takako Kondo, (unknown), Sarah C. Nabinger, (unknown), Fuqin Yin, Edward M. Chan, Menggang Yu, (unknown), Christian P. Kratz, Charlotte M. Niemeyer, Christian Flotho, Eri Hashino, Rebecca J. Chan	20
19	Helper-dependent Adenovirus-mediated Short Hairpin RNA Expression in the Liver Activates the Interferon Response 2007 ·Journal of Biological Chemistry ·Scott R. Witting, Matthew Brown, Romil Saxena, Sarah C. Nabinger, Núria Morral	27
20	Sterol uptake in Candida glabrata: Rescue of sterol auxotrophic strains 2005 ·Diagnostic Microbiology and Infectious Disease ·Martin Bard, (unknown), C. A. Pierson, (unknown), (unknown), Sarah C. Nabinger, James A. Eckstein, Robert J. Barbuch, N. Douglas Lees, S. A. Howell, Kevin C. Hazen	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact